On November 3, 2022, Edesa Biotech Inc., a Canadian clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, completed a US$3 million private placement of units, priced at-the-market.
Fasken acted for Edesa Biotech Inc., with a team led by Wojtek Baraniak and Myroslav Chwaluk, and which included Alexis Shamess and Arjun Sodhi (Articling Student).
Jurisdiction
- Ontario
